 | • レポートコード：MRC2012A7659 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、乾癬治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。乾癬治療薬の種類別市場規模（外用、経口、注射）、用途別市場規模（病院、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Merz Pharma、Galderma、Johnson & Johnson、Pfizer、Bayer、LEO Pharma、Novartis、Bristol-Myers Squibb、Valeant、GlaxoSmithKline、 ・地域別グローバル市場分析 2015年-2020年 ・乾癬治療薬の北米市場（アメリカ、カナダ、メキシコ） ・乾癬治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・乾癬治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・乾癬治療薬の南米市場（ブラジル、アルゼンチン） ・乾癬治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：外用、経口、注射 ・用途別分析：病院、ドラッグストア ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Psoriasis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Psoriasis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Psoriasis Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Psoriasis Drug market has been segmented into
External Use
Oral
Injection
By Application, Psoriasis Drug has been segmented into:
Hospital
Drugs Store
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Psoriasis Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Psoriasis Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Psoriasis Drug market.
The report offers in-depth assessment of the growth and other aspects of the Psoriasis Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Psoriasis Drug Market Share Analysis
Psoriasis Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Psoriasis Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Psoriasis Drug sales, revenue and market share for each player covered in this report.
The major players covered in Psoriasis Drug are:
AbbVie
Merz Pharma
Galderma
Johnson & Johnson
Pfizer
Bayer
LEO Pharma
Novartis
Bristol-Myers Squibb
Valeant
GlaxoSmithKline
Among other players domestic and global, Psoriasis Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Psoriasis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Psoriasis Drug, with price, sales, revenue and global market share of Psoriasis Drug in 2018 and 2019.
Chapter 3, the Psoriasis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Psoriasis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Psoriasis Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Psoriasis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Psoriasis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Psoriasis Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 External Use
1.2.3 Oral
1.2.4 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Psoriasis Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Overview of Global Psoriasis Drug Market
1.4.1 Global Psoriasis Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merz Pharma
2.2.1 Merz Pharma Details
2.2.2 Merz Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merz Pharma SWOT Analysis
2.2.4 Merz Pharma Product and Services
2.2.5 Merz Pharma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Galderma
2.3.1 Galderma Details
2.3.2 Galderma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Galderma SWOT Analysis
2.3.4 Galderma Product and Services
2.3.5 Galderma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer SWOT Analysis
2.6.4 Bayer Product and Services
2.6.5 Bayer Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 LEO Pharma
2.7.1 LEO Pharma Details
2.7.2 LEO Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 LEO Pharma SWOT Analysis
2.7.4 LEO Pharma Product and Services
2.7.5 LEO Pharma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bristol-Myers Squibb
2.9.1 Bristol-Myers Squibb Details
2.9.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bristol-Myers Squibb SWOT Analysis
2.9.4 Bristol-Myers Squibb Product and Services
2.9.5 Bristol-Myers Squibb Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Valeant
2.10.1 Valeant Details
2.10.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Valeant SWOT Analysis
2.10.4 Valeant Product and Services
2.10.5 Valeant Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 GlaxoSmithKline SWOT Analysis
2.11.4 GlaxoSmithKline Product and Services
2.11.5 GlaxoSmithKline Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Psoriasis Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Psoriasis Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Psoriasis Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Psoriasis Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Psoriasis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Psoriasis Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Psoriasis Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Psoriasis Drug Sales and Growth Rate (2015-2020)
4.3 Europe Psoriasis Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Psoriasis Drug Sales and Growth Rate (2015-2020)
4.5 South America Psoriasis Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Psoriasis Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Psoriasis Drug Sales, Revenue and Market Share by Country
5.1.1 North America Psoriasis Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Psoriasis Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Psoriasis Drug Sales and Growth Rate (2015-2020)
5.3 Canada Psoriasis Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Psoriasis Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Psoriasis Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Psoriasis Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Psoriasis Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Psoriasis Drug Sales and Growth Rate (2015-2020)
6.3 UK Psoriasis Drug Sales and Growth Rate (2015-2020)
6.4 France Psoriasis Drug Sales and Growth Rate (2015-2020)
6.5 Russia Psoriasis Drug Sales and Growth Rate (2015-2020)
6.6 Italy Psoriasis Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Psoriasis Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Psoriasis Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Psoriasis Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Psoriasis Drug Sales and Growth Rate (2015-2020)
7.3 Japan Psoriasis Drug Sales and Growth Rate (2015-2020)
7.4 Korea Psoriasis Drug Sales and Growth Rate (2015-2020)
7.5 India Psoriasis Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Psoriasis Drug Sales and Growth Rate (2015-2020)
7.7 Australia Psoriasis Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Psoriasis Drug Sales, Revenue and Market Share by Country
8.1.1 South America Psoriasis Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Psoriasis Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Psoriasis Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Psoriasis Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Psoriasis Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Psoriasis Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Psoriasis Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Psoriasis Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Psoriasis Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Psoriasis Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Psoriasis Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Psoriasis Drug Sales and Market Share by Type (2015-2020)
10.2 Global Psoriasis Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Psoriasis Drug Price by Type (2015-2020)
11 Global Psoriasis Drug Market Segment by Application
11.1 Global Psoriasis Drug Sales Market Share by Application (2015-2020)
11.2 Global Psoriasis Drug Revenue Market Share by Application (2015-2020)
11.3 Global Psoriasis Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Psoriasis Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Psoriasis Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Psoriasis Drug Market Forecast (2021-2025)
12.2.2 Europe Psoriasis Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Psoriasis Drug Market Forecast (2021-2025)
12.2.4 South America Psoriasis Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Psoriasis Drug Market Forecast (2021-2025)
12.3 Psoriasis Drug Market Forecast by Type (2021-2025)
12.3.1 Global Psoriasis Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Psoriasis Drug Market Share Forecast by Type (2021-2025)
12.4 Psoriasis Drug Market Forecast by Application (2021-2025)
12.4.1 Global Psoriasis Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Psoriasis Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Psoriasis Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Psoriasis Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Psoriasis Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Psoriasis Drug Major Business
Table 9. AbbVie Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie Psoriasis Drug Product and Services
Table 12. AbbVie Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merz Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Merz Pharma Psoriasis Drug Major Business
Table 15. Merz Pharma Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 16. Merz Pharma SWOT Analysis
Table 17. Merz Pharma Psoriasis Drug Product and Services
Table 18. Merz Pharma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Galderma Basic Information, Manufacturing Base and Competitors
Table 20. Galderma Psoriasis Drug Major Business
Table 21. Galderma Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 22. Galderma SWOT Analysis
Table 23. Galderma Psoriasis Drug Product and Services
Table 24. Galderma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Psoriasis Drug Major Business
Table 27. Johnson & Johnson Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Psoriasis Drug Product and Services
Table 30. Johnson & Johnson Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Psoriasis Drug Major Business
Table 33. Pfizer Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 34. Pfizer SWOT Analysis
Table 35. Pfizer Psoriasis Drug Product and Services
Table 36. Pfizer Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bayer Basic Information, Manufacturing Base and Competitors
Table 38. Bayer Psoriasis Drug Major Business
Table 39. Bayer Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 40. Bayer SWOT Analysis
Table 41. Bayer Psoriasis Drug Product and Services
Table 42. Bayer Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 44. LEO Pharma Psoriasis Drug Major Business
Table 45. LEO Pharma Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 46. LEO Pharma SWOT Analysis
Table 47. LEO Pharma Psoriasis Drug Product and Services
Table 48. LEO Pharma Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis Basic Information, Manufacturing Base and Competitors
Table 50. Novartis Psoriasis Drug Major Business
Table 51. Novartis Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 52. Novartis SWOT Analysis
Table 53. Novartis Psoriasis Drug Product and Services
Table 54. Novartis Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 56. Bristol-Myers Squibb Psoriasis Drug Major Business
Table 57. Bristol-Myers Squibb Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 58. Bristol-Myers Squibb SWOT Analysis
Table 59. Bristol-Myers Squibb Psoriasis Drug Product and Services
Table 60. Bristol-Myers Squibb Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Valeant Basic Information, Manufacturing Base and Competitors
Table 62. Valeant Psoriasis Drug Major Business
Table 63. Valeant Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 64. Valeant SWOT Analysis
Table 65. Valeant Psoriasis Drug Product and Services
Table 66. Valeant Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 68. GlaxoSmithKline Psoriasis Drug Major Business
Table 69. GlaxoSmithKline Psoriasis Drug Total Revenue (USD Million) (2017-2018)
Table 70. GlaxoSmithKline SWOT Analysis
Table 71. GlaxoSmithKline Psoriasis Drug Product and Services
Table 72. GlaxoSmithKline Psoriasis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Psoriasis Drug Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Psoriasis Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Psoriasis Drug Sales by Regions (2015-2020) (K Units)
Table 76. Global Psoriasis Drug Sales Market Share by Regions (2015-2020)
Table 77. Global Psoriasis Drug Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Psoriasis Drug Sales by Countries (2015-2020) (K Units)
Table 79. North America Psoriasis Drug Sales Market Share by Countries (2015-2020)
Table 80. North America Psoriasis Drug Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Psoriasis Drug Revenue Market Share by Countries (2015-2020)
Table 82. Europe Psoriasis Drug Sales by Countries (2015-2020) (K Units)
Table 83. Europe Psoriasis Drug Sales Market Share by Countries (2015-2020)
Table 84. Europe Psoriasis Drug Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Psoriasis Drug Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Psoriasis Drug Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Psoriasis Drug Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Psoriasis Drug Sales by Countries (2015-2020) (K Units)
Table 89. South America Psoriasis Drug Sales Market Share by Countries (2015-2020)
Table 90. South America Psoriasis Drug Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Psoriasis Drug Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Psoriasis Drug Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Psoriasis Drug Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Psoriasis Drug Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Psoriasis Drug Revenue Market Share by Countries (2015-2020)
Table 96. Global Psoriasis Drug Sales by Type (2015-2020) (K Units)
Table 97. Global Psoriasis Drug Sales Share by Type (2015-2020)
Table 98. Global Psoriasis Drug Revenue by Type (2015-2020) (USD Million)
Table 99. Global Psoriasis Drug Revenue Share by Type (2015-2020)
Table 100. Global Psoriasis Drug Sales by Application (2015-2020) (K Units)
Table 101. Global Psoriasis Drug Sales Share by Application (2015-2020)
Table 102. Global Psoriasis Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Psoriasis Drug Market Share Forecast by Regions (2021-2025)
Table 104. Global Psoriasis Drug Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Psoriasis Drug Market Share Forecast by Type (2021-2025)
Table 106. Global Psoriasis Drug Sales Forecast by Application (2021-2025)
Table 107. Global Psoriasis Drug Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Psoriasis Drug Picture
Figure 2. Global Sales Market Share of Psoriasis Drug by Type in 2019
Figure 3. External Use Picture
Figure 4. Oral Picture
Figure 5. Injection Picture
Figure 6. Psoriasis Drug Sales Market Share by Application in 2018
Figure 7. Hospital Picture
Figure 8. Drugs Store Picture
Figure 9. Global Psoriasis Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Psoriasis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Psoriasis Drug Sales Market Share by Manufacturer in 2019
Figure 30. Global Psoriasis Drug Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Psoriasis Drug Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Psoriasis Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Psoriasis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Psoriasis Drug Revenue Market Share by Regions (2015-2020)
Figure 37. Global Psoriasis Drug Revenue Market Share by Regions in 2018
Figure 38. North America Psoriasis Drug Sales and Growth Rate (2015-2020)
Figure 39. Europe Psoriasis Drug Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Psoriasis Drug Sales and Growth Rate (2015-2020)
Figure 41. South America Psoriasis Drug Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Psoriasis Drug Sales and Growth Rate (2015-2020)
Figure 43. North America Psoriasis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Psoriasis Drug Sales Market Share by Countries (2015-2020)
Figure 45. North America Psoriasis Drug Sales Market Share by Countries in 2018
Figure 46. North America Psoriasis Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Psoriasis Drug Revenue Market Share by Countries in 2018
Figure 48. United States Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Psoriasis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Psoriasis Drug Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Psoriasis Drug Revenue Market Share by Countries in 2019
Figure 54. Germany Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Psoriasis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Psoriasis Drug Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Psoriasis Drug Revenue Market Share by Regions 2019
Figure 62. China Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Psoriasis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Psoriasis Drug Sales Market Share by Countries in 2019
Figure 69. South America Psoriasis Drug Revenue Market Share by Countries in 2019
Figure 70. Brazil Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Psoriasis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Psoriasis Drug Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Psoriasis Drug Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Psoriasis Drug Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Psoriasis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Psoriasis Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Psoriasis Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Psoriasis Drug Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Psoriasis Drug Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Psoriasis Drug Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Psoriasis Drug Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Psoriasis Drug Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
全身性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcoho…- 慢性尋常性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type…
- 尋常性乾癬治療の世界市場（～2026年） Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling, inflamed skin that is often quite itchy. When treating plaque psoriasis, it must be remembered that topical medications and light will have difficulty penetrating through th…
- 乾癬治療薬の世界市場（～2026年） Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to…
- アフィニトール錠の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Afinitor Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Afinitor Drug market report pro…